Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tubulin | 7 | 2011 | 203 | 1.640 |
Why?
|
| Colorectal Neoplasms | 14 | 2023 | 3662 | 1.450 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 388 | 0.940 |
Why?
|
| Microtubules | 4 | 2011 | 330 | 0.930 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2023 | 1408 | 0.820 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2020 | 1606 | 0.750 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2017 | 123 | 0.680 |
Why?
|
| Vincristine | 1 | 2023 | 1572 | 0.660 |
Why?
|
| Peer Review, Research | 1 | 2017 | 66 | 0.580 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 1437 | 0.500 |
Why?
|
| Fluorouracil | 2 | 2016 | 1987 | 0.410 |
Why?
|
| CHO Cells | 7 | 2012 | 323 | 0.400 |
Why?
|
| Cricetulus | 6 | 2011 | 215 | 0.380 |
Why?
|
| Cricetinae | 7 | 2012 | 793 | 0.380 |
Why?
|
| Cell Proliferation | 7 | 2023 | 7307 | 0.370 |
Why?
|
| Centrosome | 1 | 2011 | 107 | 0.370 |
Why?
|
| Cell Movement | 2 | 2017 | 2504 | 0.360 |
Why?
|
| Drug Resistance | 2 | 2009 | 615 | 0.340 |
Why?
|
| Paclitaxel | 4 | 2011 | 2099 | 0.340 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 4069 | 0.330 |
Why?
|
| Tubulin Modulators | 1 | 2009 | 65 | 0.330 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2016 | 5429 | 0.320 |
Why?
|
| Protein Isoforms | 1 | 2011 | 861 | 0.310 |
Why?
|
| Neoplastic Stem Cells | 4 | 2018 | 1469 | 0.300 |
Why?
|
| Cell Line, Tumor | 10 | 2023 | 14882 | 0.280 |
Why?
|
| Mammals | 1 | 2008 | 374 | 0.280 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2016 | 1153 | 0.270 |
Why?
|
| Endothelial Cells | 3 | 2018 | 1047 | 0.270 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3350 | 0.260 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 2215 | 0.240 |
Why?
|
| Apoptosis | 3 | 2019 | 7862 | 0.220 |
Why?
|
| Genes, src | 1 | 2023 | 28 | 0.220 |
Why?
|
| HCT116 Cells | 3 | 2019 | 354 | 0.220 |
Why?
|
| Animals | 19 | 2023 | 62826 | 0.210 |
Why?
|
| HT29 Cells | 3 | 2018 | 157 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2018 | 2094 | 0.210 |
Why?
|
| Mice | 11 | 2023 | 36039 | 0.200 |
Why?
|
| Carcinogenesis | 2 | 2020 | 1032 | 0.200 |
Why?
|
| Organophosphates | 1 | 2002 | 40 | 0.200 |
Why?
|
| Ribonucleoproteins | 1 | 2002 | 114 | 0.190 |
Why?
|
| Pyridones | 1 | 2023 | 361 | 0.180 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2012 | 643 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2023 | 3929 | 0.170 |
Why?
|
| Mitosis | 3 | 2012 | 691 | 0.170 |
Why?
|
| Antineoplastic Agents, Phytogenic | 3 | 2013 | 896 | 0.170 |
Why?
|
| Dasatinib | 1 | 2023 | 881 | 0.160 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 130 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2023 | 4964 | 0.160 |
Why?
|
| ADAM Proteins | 2 | 2016 | 114 | 0.150 |
Why?
|
| Publications | 1 | 2018 | 53 | 0.150 |
Why?
|
| Receptor, ErbB-3 | 1 | 2018 | 126 | 0.150 |
Why?
|
| Cell Communication | 2 | 2018 | 520 | 0.150 |
Why?
|
| Ethics, Research | 1 | 2018 | 67 | 0.150 |
Why?
|
| Fusobacterium Infections | 1 | 2017 | 30 | 0.140 |
Why?
|
| Chemokine CCL20 | 1 | 2017 | 39 | 0.140 |
Why?
|
| Blotting, Western | 3 | 2016 | 3651 | 0.140 |
Why?
|
| Nanog Homeobox Protein | 1 | 2017 | 64 | 0.140 |
Why?
|
| Fusobacterium nucleatum | 1 | 2017 | 32 | 0.140 |
Why?
|
| RNA | 1 | 2002 | 1067 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 1726 | 0.140 |
Why?
|
| Paracrine Communication | 1 | 2017 | 132 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 1571 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 4519 | 0.130 |
Why?
|
| Mutation | 8 | 2023 | 15861 | 0.130 |
Why?
|
| Humans | 27 | 2023 | 271062 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 791 | 0.130 |
Why?
|
| Publishing | 1 | 2017 | 195 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 371 | 0.130 |
Why?
|
| Research | 1 | 2018 | 427 | 0.130 |
Why?
|
| Pseudogenes | 1 | 2015 | 91 | 0.120 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 441 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2017 | 1047 | 0.120 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 220 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2017 | 428 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 618 | 0.120 |
Why?
|
| Spindle Apparatus | 2 | 2011 | 112 | 0.110 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2013 | 16 | 0.110 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 364 | 0.110 |
Why?
|
| Mice, Nude | 5 | 2022 | 4361 | 0.110 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 323 | 0.110 |
Why?
|
| Monocytes | 1 | 2017 | 787 | 0.110 |
Why?
|
| RNA Interference | 2 | 2014 | 1398 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 1146 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1160 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2018 | 12221 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 1600 | 0.110 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 4641 | 0.110 |
Why?
|
| HeLa Cells | 2 | 2008 | 1719 | 0.100 |
Why?
|
| Centromere | 1 | 2012 | 137 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 1004 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2014 | 834 | 0.100 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 6784 | 0.100 |
Why?
|
| Macrophages | 1 | 2018 | 1373 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2016 | 5834 | 0.090 |
Why?
|
| Guanosine Triphosphate | 1 | 2011 | 106 | 0.090 |
Why?
|
| Camptothecin | 1 | 2013 | 538 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 556 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2017 | 802 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2016 | 4993 | 0.090 |
Why?
|
| Decision Making | 1 | 2017 | 1242 | 0.090 |
Why?
|
| ras Proteins | 1 | 2014 | 803 | 0.090 |
Why?
|
| Research Design | 1 | 2017 | 1573 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2013 | 377 | 0.090 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2016 | 1346 | 0.080 |
Why?
|
| Binding Sites, Antibody | 1 | 2009 | 136 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 674 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2011 | 305 | 0.080 |
Why?
|
| Epitope Mapping | 1 | 2009 | 110 | 0.080 |
Why?
|
| Colony-Forming Units Assay | 1 | 2009 | 255 | 0.080 |
Why?
|
| Anaphase | 1 | 2008 | 54 | 0.080 |
Why?
|
| Chromosome Segregation | 1 | 2008 | 82 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 6187 | 0.070 |
Why?
|
| Mycobacteriophages | 1 | 2007 | 2 | 0.070 |
Why?
|
| Chromosomes | 1 | 2008 | 323 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2009 | 884 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 278 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 1091 | 0.070 |
Why?
|
| Acetylation | 1 | 2008 | 519 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 658 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2009 | 1666 | 0.070 |
Why?
|
| Genes, Viral | 1 | 2007 | 257 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2012 | 2153 | 0.070 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2007 | 196 | 0.070 |
Why?
|
| Cell Death | 1 | 2008 | 690 | 0.070 |
Why?
|
| Gene Expression | 3 | 2014 | 3679 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2013 | 2959 | 0.060 |
Why?
|
| Culture Media, Conditioned | 2 | 2018 | 257 | 0.060 |
Why?
|
| ADAM17 Protein | 2 | 2016 | 17 | 0.060 |
Why?
|
| Proteomics | 1 | 2012 | 1437 | 0.060 |
Why?
|
| Heterografts | 2 | 2018 | 745 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 1522 | 0.060 |
Why?
|
| Cell Survival | 2 | 2022 | 3085 | 0.060 |
Why?
|
| Transfection | 1 | 2008 | 3169 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2018 | 1835 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2013 | 209 | 0.050 |
Why?
|
| RNA, Small Nuclear | 1 | 2002 | 55 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 362 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 165 | 0.050 |
Why?
|
| RNA Helicases | 1 | 2002 | 103 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 594 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 414 | 0.050 |
Why?
|
| Kinetochores | 2 | 2012 | 28 | 0.050 |
Why?
|
| Cell Line | 2 | 2008 | 5437 | 0.040 |
Why?
|
| Autoantigens | 1 | 2002 | 245 | 0.040 |
Why?
|
| Pharmacogenomic Testing | 1 | 2020 | 46 | 0.040 |
Why?
|
| Isomerism | 1 | 2019 | 66 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2002 | 262 | 0.040 |
Why?
|
| Quinazolines | 2 | 2018 | 953 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 3419 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 7936 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 1502 | 0.040 |
Why?
|
| Professional Practice | 1 | 2018 | 81 | 0.040 |
Why?
|
| Palmitates | 1 | 1997 | 23 | 0.040 |
Why?
|
| RNA, Bacterial | 1 | 2017 | 84 | 0.040 |
Why?
|
| Acyltransferases | 1 | 1997 | 66 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2020 | 334 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 16603 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2020 | 1015 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2017 | 151 | 0.040 |
Why?
|
| Research Personnel | 1 | 2018 | 154 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 203 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 3073 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2019 | 1369 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1997 | 359 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2017 | 163 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4795 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 635 | 0.030 |
Why?
|
| Students | 1 | 2018 | 330 | 0.030 |
Why?
|
| RNA, Antisense | 1 | 2015 | 78 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2017 | 257 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 508 | 0.030 |
Why?
|
| Palmitic Acids | 1 | 1994 | 17 | 0.030 |
Why?
|
| Protein Binding | 1 | 2002 | 3536 | 0.030 |
Why?
|
| Erythrocyte Membrane | 1 | 1994 | 40 | 0.030 |
Why?
|
| Interleukins | 1 | 2017 | 341 | 0.030 |
Why?
|
| Phenotype | 2 | 2018 | 6464 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 676 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2022 | 2379 | 0.030 |
Why?
|
| Internet | 1 | 2018 | 697 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 1212 | 0.030 |
Why?
|
| Blood Proteins | 1 | 1994 | 300 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 459 | 0.030 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2013 | 85 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1997 | 816 | 0.030 |
Why?
|
| Jagged-1 Protein | 1 | 2013 | 103 | 0.030 |
Why?
|
| Liposomes | 1 | 2014 | 713 | 0.030 |
Why?
|
| Liver | 1 | 2022 | 3124 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 201 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2020 | 1732 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 9084 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2015 | 6485 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 1617 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 3653 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 812 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 917 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 2993 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 1124 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1084 | 0.020 |
Why?
|
| Demecolcine | 1 | 2010 | 20 | 0.020 |
Why?
|
| Proteolysis | 1 | 2012 | 380 | 0.020 |
Why?
|
| Epothilones | 1 | 2010 | 55 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2014 | 586 | 0.020 |
Why?
|
| Vinblastine | 1 | 2010 | 462 | 0.020 |
Why?
|
| Metaphase | 1 | 2008 | 124 | 0.020 |
Why?
|
| Aurora Kinase B | 1 | 2008 | 68 | 0.020 |
Why?
|
| Aurora Kinases | 1 | 2008 | 193 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 15861 | 0.020 |
Why?
|
| Mycobacterium smegmatis | 1 | 2007 | 8 | 0.020 |
Why?
|
| Defective Viruses | 1 | 2007 | 38 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2007 | 76 | 0.020 |
Why?
|
| Proteasome Inhibitors | 1 | 2008 | 238 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2013 | 1328 | 0.020 |
Why?
|
| Genes, Essential | 1 | 2007 | 57 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2007 | 235 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6898 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 603 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5908 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 542 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 3226 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2007 | 494 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2007 | 730 | 0.010 |
Why?
|
| Benzamides | 1 | 2008 | 1883 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 1037 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2015 | 2909 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 13979 | 0.010 |
Why?
|
| Biomarkers | 1 | 2013 | 5107 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 7470 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 10701 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 4190 | 0.010 |
Why?
|
| Female | 3 | 2017 | 148623 | 0.010 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 1997 | 3 | 0.010 |
Why?
|
| Acylation | 1 | 1997 | 23 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1997 | 121 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 30966 | 0.010 |
Why?
|
| Spectrin | 1 | 1997 | 83 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1997 | 582 | 0.010 |
Why?
|
| Hydroxylamines | 1 | 1994 | 7 | 0.010 |
Why?
|
| Hydroxylamine | 1 | 1994 | 3 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1994 | 43 | 0.010 |
Why?
|
| Tritium | 1 | 1994 | 268 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 615 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1994 | 624 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 13112 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1994 | 388 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 1994 | 542 | 0.010 |
Why?
|
| Kinetics | 1 | 1994 | 2246 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 73250 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 81619 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 14682 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 90103 | 0.010 |
Why?
|
| Male | 1 | 2017 | 128516 | 0.000 |
Why?
|